KIDNEY TRANSPLANTATION

This study looked at kidney transplant recipients who already had one skin cancer. It compared two groups: one switched to rapamycin, the other stayed on standard drugs (calcineurin inhibitors). The goal was to see if rapamycin could lower the chance of getting new skin cancers o…

This study tested whether giving donor stem cells along with a kidney transplant could allow recipients to safely stop taking anti-rejection drugs. It involved 88 pairs of HLA-identical siblings. The main goal was to see if patients could stop immunosuppression one year after tra…

This study tested a new medicine called ASKP1240 in 149 people who received a new kidney. The goal was to see if it could help prevent the body from rejecting the new kidney. The study compared different combinations of drugs to find a safer and more effective way to protect the …

This study tested a special stent with a magnetic end in 67 children with urinary tract problems or kidney transplants. The goal was to see if doctors could remove the stent without general anesthesia, using a magnetic tool instead. The approach aims to make the procedure easier …

This study looked at 24 kidney transplant recipients to see if substances in a small piece of the donor kidney could predict how well the organ would work after transplant. Researchers tested blood, urine, and biopsy samples to find risk factors for early organ problems or reject…

This study followed 241 kidney transplant patients to track changes in a specific antibody (AT1R-Ab) before and after surgery. Researchers wanted to see if these antibody levels relate to kidney function and whether the transplanted kidney survives longer. The goal is to help doc…

This study looked at how pancreas-kidney transplants change bile acids and blood sugar control in people with type 1 diabetes and kidney disease. Researchers measured bile acid levels and glucose tolerance one year after transplant in 50 patients. Results were compared to kidney-…